https://www.avient.com/sites/default/files/2025-01/ColorWorks Sao Paulo Case Study Snapshot _Portuguese.pdf
EMPRESA LÍDER EM BENS DE CONSUMO E M B A L A G E M – C U I D A D O S C O R P O R A I S • Ofereça um retorno rápido em novos designs para melhorar a velocidade de lançamento no mercado • Crie consistência visual e identidade de marca ao navegar pelos esforços de desenvolvimento com partes externas • Entregue orientação sobre tendências de cores • Entregamos mais de 20 cores personalizadas e aprovadas, utilizando o conhecimento do mercado e das tendências • Empregamos sessões de colaboração virtuais e no local para uma resposta rápida a decisões cruciais sobre cores • Trabalhamos com todas as partes necessárias, incluindo empresas de design, fabricantes e equipes de engenharia interna para proteger a integridade da marca Centros de design e tecnologia ColorWorks – São Paulo PRINCIPAIS REQUISITOS POR QUE A AVIENT?
https://www.avient.com/sites/default/files/2022-12/15719637-22-AVIENT ESPAÑA SL-INGLES.pdf
C/ Valportillo Primera 22-24, Edificio Caoba, 28108 Alcobendas - Madrid, España This certificate is valid, subject to the general and specific terms and conditions of certification services STANDARD Bureau Veritas certification certifies that the Management System has been audited and found to be in accordance with the requirements of standard: Awarded to Certification https://e-cer.bureauveritas.com/WJLVJDYG9LKV98RP6JCHF8NPSKES0NHDXDPLOWOT1TB290DE4LNZC0JCBAI2BVWEAZ1GJWC8BMDC2TXFBGVDXP3YXG0JLAVMFN3HLEWBLUWJGXCY5PAJ8QKKSTVJYSZ9M9 https://e-cer.bureauveritas.com/WJLVJDYG9LKV98RP6JCHF8NPSKES0NHDXDPLOWOT1TB290DE4LNZC0JCBAI2BVWEAZ1GJWC8BMDC2TXFBGVDXP3YXG0JLAVMFN3HLEWBLUWJGXCY5PAJ8QKKSTVJYSZ9M9 https://e-cer.bureauveritas.com/WJLVJDYG9LKV98RP6JCHF8NPSKES0NHDXDPLOWOT1TB290DE4LNZC0JCBAI2BVWEAZ1GJWC8BMDC2TXFBGVDXP3YXG0JLAVMFN3HLEWBLUWJGXCY5PAJ8QKKSTVJYSZ9M9 https://e-cer.bureauveritas.com/WJLVJDYG9LKV98RP6JCHF8NPSKES0NHDXDPLOWOT1TB290DE4LNZC0JCBAI2BVWEAZ1GJWC8BMDC2TXFBGVDXP3YXG0JLAVMFN3HLEWBLUWJGXCY5PAJ8QKKSTVJYSZ9M9 https://e-cer.bureauveritas.com/WJLVJDYG9LKV98RP6JCHF8NPSKES0NHDXDPLOWOT1TB290DE4LNZC0JCBAI2BVWEAZ1GJWC8BMDC2TXFBGVDXP3YXG0JLAVMFN3HLEWBLUWJGXCY5PAJ8QKKSTVJYSZ9M9 https://e-cer.bureauveritas.com/WJLVJDYG9LKV98RP6JCHF8NPSKES0NHDXDPLOWOT1TB290DE4LNZC0JCBAI2BVWEAZ1GJWC8BMDC2TXFBGVDXP3YXG0JLAVMFN3HLEWBLUWJGXCY5PAJ8QKKSTVJYSZ9M9 https://e-cer.bureauveritas.com/WJLVJDYG9LKV98RP6JCHF8NPSKES0NHDXDPLOWOT1TB290DE4LNZC0JCBAI2BVWEAZ1GJWC8BMDC2TXFBGVDXP3YXG0JLAVMFN3HLEWBLUWJGXCY5PAJ8QKKSTVJYSZ9M9 2022-12-15T10:52:43+0100 Authenticity and Integrity 2022-12-15T10:53:51+0100 BUREAU VERITAS CERTIFICATION
https://www.avient.com/sites/default/files/2023-11/ISO 9001_EN_Changzhou.pdf
China Date of Issue:2021-10-28 Date of Expiry:2024-10-27 证书编号 E受审核方 英文组织机构代码 认证模式全称 E认证范围 E注册地址 E生产办公地址 E注册日期 E有效期至 E初次颁证日期 二维码
https://www.avient.com/sites/default/files/2023-02/AVNT Q4 2022 Earnings Presentation.pdf
Microsoft PowerPoint - AVNT Q4 2022 Earnings Presentation AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 2 R E S U L T S A N D 2 0 2 3 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R U A RY 1 5 , 2 0 2 3 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
GUIDANCE DEBT / LEVERAGE REDUCTION • Completed sale of Distribution and paid down $750M of debt in November • Strong free cash flow in fourth quarter reduced leverage and enabled paydown of additional $200M of debt • Fixed/Floating Debt Ratio 63/37 • Proven track record of deleveraging following acquisitions through consistent free cash flow generation $725 $725 $725 $575 $500 $400 $600 $525 $425 $650 $650 $650 $600 $2.40B $2.20B 2030 Notes 2029 Term Loan 2026 Term Loan 2025 Notes After Distribution Divestiture Year-End 4 Year-End Leverage 3.8x 3.1x 2.9x 2023 Notes After Avient Protective Materials Acquisition $3.15B 2022 TRANSFORMATIONAL PORTFOLIO ENHANCEMENTS 5 EBITDA margins expanded from 12% to 16% Diversified end markets with reduced exposure to more cyclical industries Dyneema® Acquisition $1.48B acquisition strengthens composites platform Significantly improved EBITDA margins $950M divestiture results in 100% specialty sales Strong exit multiple of 10x TTM EBITDA despite market volatility Distribution Divestiture Improved Portfolio GROWING COMPOSITES PLATFORM CONTRIBUTIONS TO SEM SEGMENT 6 Note: 2022 is pro forma for Avient Protective Materials 2016 Sales 2022 Sales Advanced Composites 51% $560M $1,300M Advanced Composites 9% COMPOSITES PORTFOLIO D Y N E E M A ® E X P A N D S O U R E N G I N E E R E D F I B E R S A N D T A P E S T E C H N O L O G Y LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers 7 ADVANCED COMPOSITES PERFORMANCE 8 (1) Pro forma for the acquisition of Avient Protective Materials Sales $51 $84 $212 $668 2016 2018 2020 2022 $4 $10 $41 $169 2016 2018 2020 2022 EBITDA (1) (1) ($ in millions) PORTFOLIO EVOLUTION AND EPS EXPANSION 9 Adj.
Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 28 79 87 81 79 76 73 90 77 76 75 73 64 59 33 A vi en t K W R P P G F U L A V Y R P M F M C C E A S H H X L E C L H U N E M N S C L MULTIPLE EXPANSION Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of February 13, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.89.
https://www.avient.com/sites/default/files/2023-03/AVNT Mar 2023 Earnings Presentation.pdf
Microsoft PowerPoint - AVNT Mar 2023 Earnings Presentation AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) M A R C H 2 0 2 3 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
GUIDANCE DEBT / LEVERAGE REDUCTION • Completed sale of Distribution and paid down $750M of debt in November • Strong free cash flow in fourth quarter reduced leverage and enabled paydown of additional $200M of debt • Fixed/Floating Debt Ratio 63/37 • Proven track record of deleveraging following acquisitions through consistent free cash flow generation $725 $725 $725 $575 $500 $400 $600 $525 $425 $650 $650 $650 $600 $2.40B $2.20B 2030 Notes 2029 Term Loan 2026 Term Loan 2025 Notes After Distribution Divestiture Year-End 8 Year-End Leverage 3.8x 3.1x 2.9x 2023 Notes After Avient Protective Materials Acquisition $3.15B 2022 TRANSFORMATIONAL PORTFOLIO ENHANCEMENTS 9 EBITDA margins expanded from 12% to 16% Diversified end markets with reduced exposure to more cyclical industries Dyneema® Acquisition $1.48B acquisition strengthens composites platform Significantly improved EBITDA margins $950M divestiture results in 100% specialty sales Strong exit multiple of 10x TTM EBITDA despite market volatility Distribution Divestiture Improved Portfolio GROWING COMPOSITES PLATFORM CONTRIBUTIONS TO SEM SEGMENT 10 Note: 2022 is pro forma for Avient Protective Materials 2016 Sales 2022 Sales Advanced Composites 51% $560M $1,300M Advanced Composites 9% COMPOSITES PORTFOLIO D Y N E E M A ® E X P A N D S O U R E N G I N E E R E D F I B E R S A N D T A P E S T E C H N O L O G Y LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers 11 ADVANCED COMPOSITES PERFORMANCE 12 (1) Pro forma for the acquisition of Avient Protective Materials Sales $51 $84 $212 $668 2016 2018 2020 2022 $4 $10 $41 $169 2016 2018 2020 2022 EBITDA (1) (1) ($ in millions) PORTFOLIO EVOLUTION AND EPS EXPANSION 13 Adj.
Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 31 79 87 81 79 76 73 90 77 76 75 73 64 59 33 A vi en t K W R P P G F U L A V Y R P M F M C C E A S H H X L E C L H U N E M N S C L MULTIPLE EXPANSION Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of February 13, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.89.
https://www.avient.com/sites/default/files/2020-10/investing-in-avient.pdf
PEER COMPARISONS 16 2 3 2 3 3 3 6 3 4 4 4 4 5 5 6 6 7 8 9 23 A vi e nt A vi e nt ( E xc l.
D is t. ) R P M K W R P P G F U L G C P F M C IF F H X L H U N F O E E M N E C L S C L K R A A S H C E G R A A LB As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Source: Capital IQ market data as of August 24, 2020 Median: 84% Median: 75% HIGH FREE CASH FLOW CONVERSION 3.1x 2.6x 0.5x 1.9x 2.8x 3.1x 4.5x -0.1x 1.8x 1.9x 2.2x 2.3x 2.4x 2.9x 3.0x 3.0x 3.2x 3.4x 3.4x 3.8x 3.9x 4.8x A vi en t ( 20 P F ) A vi en t ( 21 E ) G C P P P G R P M K W R F U L S C L B N R H U N E C L C E F M C A S H H X L E M N G R A A L B IF F U N V R K R A F O E Net Debt / 2021E EBITDA (1) We typically operate at 2.5–3.0x net debt to EBITDA.
https://www.avient.com/sites/default/files/2021-03/avient-march-ir-fermium_0.pdf
Microsoft PowerPoint - Avient March IR - Fermium AVIENT CORPORATION (NYSE: AVNT) M A R C H 1 8 , 2 0 2 1 I R M E E T I N G S H O S T E D B Y F E R M I U M R E S E A R C H DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
D is t. ) K W R R P M P P G A V Y F U L G C P F M C H X L IF F F O E H U N E C L K R A E M N A S H C E S C L G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of March 12, 2021 Avient reflects 2021 estimated revenue of $4,100M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 26 Avient reflects 2021 estimated EBITDA of $510M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 11.3 18.6 14.3 13.6 13.3 12.2 10.7 28.8 26.3 23.3 14.6 12.4 11.7 11.6 11.2 11.0 10.6 10.3 9.6 9.1 8.5 7.2 A vi en t K W R A V Y R P M P P G G C P F U L H X L A L B E C L IF F F M C A S H F O E B N R C E G R A E M N S C L U N V R K R A H U N Median: 11.2xMedian: 13.5x SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2022-07/ECCOH_ PF 4142 - Gel Filled Central Loose Tube Cable - Application Snapshot.pdf
EUROPEAN CABLE MANUFACTURER G E L - F I L L E D C E N T R A L L O O S E T U B E C A B L E S • Fire performance: CPR classification Cca-s1, d0, a1 • Resistance to chemicals and filling compounds • Rigidity close to PBT • Melting point higher than 100°C • Developed a custom formulation to reach required rigidity • Eliminated hydrolysis experienced with previous PBT material • Provided expertise in process improvement to help the customer achieve a more competitive processing speed ECCOH™ PF 4142 Formulation KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2020-11/investing-in-avient_0.pdf
D is t. ) R P M K W R P P G F U L A V Y G C P F M C IF F H X L H U N F O E E M N E C L S C L K R A A S H C E G R A A L B Median: 5%Median: 3% Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Source: Bloomberg market data as of November 9, 2020 Median: 82% Median: 73% HIGH FREE CASH FLOW CONVERSION 83 86 85 85 80 78 58 88 83 81 79 77 76 73 73 72 72 67 64 63 60 6 A v ie n t K W R R P M P P G F U L A V Y G C P F M C IF F U N V R B N R E M N E C L C E H X L F O E A S H G R A H U N K R A S C L A L B Net Debt / 2021E EBITDA (1) We typically operate at 2.5–3.0x net debt to EBITDA.
Using consensus EBITDA of $466M per Bloomberg Source: Bloomberg market data as of November 9, 2020 OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 9.7 18.1 14.0 14.0 13.6 11.7 10.2 23.8 18.7 17.7 13.7 12.2 11.4 11.4 11.4 11.0 10.4 9.5 9.2 8.4 8.3 7.6 A v ie n t K W R R P M P P G A V Y G C P F U L E C L A L B H X L IF F F M C C E F O E A S H B N R G R A S C L E M N U N V R H U N K R A Median: 11.4xMedian: 13.8x SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2021-05/lubrione-ear-protection-case-study-one-pager.pdf
E A R D E F E N D E R B R A C K E T • Minimize shrinkage • Good mechanical resistance • Good wear resistance • Collaborated with Avient Design to provide detailed material analysis and recommendations within one month of initial customer enquiry • Demonstrated material performance and compatibility with customer’s existing manufacturing process using mold flow analysis • Provided an internally lubricated material allowing customer to streamline manufacturing process LubriOne™ Internally Lubricated Formulation KEY REQUIREMENTS WHY AVIENT?